Las Vegas, NV -- (SBWIRE) -- 12/13/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB), Genie Energy Ltd (NYSE:GNE), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), EnteroMedics Inc (NASDAQ:ETRM)
Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) managed to keep its fall at -1.96% on below -normal volume of 1.69M shares. The stock settled at $2 after floating in a range of $1.99 to $2.09. Its latest price has reached market capitalization of $268.69 million. Its 52-week range has been $1.11 to $3.59. Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents.
Has NAVB Found The Bottom and Ready To Move Up? Find Out Here
Genie Energy Ltd (NYSE:GNE) traded down on a volume of 1.66 million, higher than its standard daily volume. Shares have dropped-2.04% to $10.09. Over the last twelve months, the stock has gained 49.04% and faced a worst price of $6.51. Genie Energy Ltd., together with its subsidiaries, engages in supplying electricity and natural gas to residential and small business customers in New York, New Jersey, Pennsylvania, and Maryland. It also produces transportation fuels from the oil shale and other unconventional fuel resources, as well as holds and manages interests in oil shale projects in Colorado and Israel.
Has GNE Found The Bottom And Ready To Gain Momentum? Find Out Here
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) settled -3.59% lower at $1.88 on above-normal volume of 1.63M shares during the last trading day. The stock has its 12-month high at $8.94 and 52-week low price was $1.80. It traded in a range of $1.80 to $1.97 during the last trading day. AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, operates as a cancer therapeutics company. The company engages in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform.
Will AVEO Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, EnteroMedics Inc (NASDAQ:ETRM) was up on low volume, trading at a volume of 1.61M versus its average daily volume of 2.10 million shares. At $1.95, the stock has attained market capitalization of 118.56 million. EnteroMedics Inc., a development stage medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses.
Will ETRM Continue To Move Higher? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)